The imidazo [1,5-a] pyridine core is a valuable scaffold for preparing electronic devices, N-heterocyclic carbenes, and pharmaceutical leads. 1 Representative of this bioactivity is the kinase inhibitor 1 that is currently in phase I trials as a tumour inhibitor 2 and the imidazo[1,5-a]quinolone 2 that was identified as a neurokinin antagonist with potential for alleviating side effects from chemotherapy and surgery. 3 The role of imidazo[1,5-a]pyridine as a pharmacophore, and the paucity of methods for synthesizing the heterocycle core, 4 stimulated a new strategy that exploits the under-developed chemistry of metalated isonitriles. Isonitriles are challenging to deprotonate because of the low kinetic and thermodynamic acidity of the protons adjacent to the isonitrile group. 6 Once deprotonated, metalated isonitriles are prone to self- Exploratory arylations were probed with 2-chloropyridine (6a) and lithiated benzylisonitrile because benzylisonitrile (4a) is commercially available and readily deprotonated by treatment with BuLi (Scheme 1). 7b Optimization experiments revealed that deprotonation was best accomplished at -78 °C for 5 minutes; longer reaction times led to a diminished yield through formation of high molecular weight materials assumed to arise from selfcondensation. After generating lithiated benzylisonitrile, 2-chloropyridine was added and, after 30 min, the reaction was allowed to warm to rt. Reaction monitoring revealed that the alkylation did not proceed until 0 °C, though the reaction was slow and best coaxed toward completion by warming to rt. The optimized procedure gave imidazo[1,5-a]pyridine 8a 9 in 29% yield (Scheme 1), though exactly the same procedure with 2-chloro-6-methylpyridine (6b) gave 8b in 72% yield. The significant yield increase was suspected to arise from proton transfers involving the 6-methyl group, 10 a suspicion subsequently confirmed by deuterium labeling. 11 Recognition of the potential benefit of a weak acid led to screening of bases with conjugate acids capable of facilitating proton transfer. KHMDS emerged as the most effective base affording the imidazo[1,5-a]pyridine 8a in 53% yield from benzylisonitrile (4a).
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Please do not adjust margins Having gained insight into the imidazo[1,5-a]pyridine synthesis, the substrate scope was examined (Table 1) . Methyl substitution on the pyridine ring is readily tolerated (entries 1-2) as are bromine substituents (entries 3-4). However, the fluorine substituent was competitively displaced through nucleophilic aromatic substitution (entry 5). 12 Phenyl and methoxy substituents on the aromatic ring of benzylisonitrile are tolerated (4b and 4c, entries 6-7) as are the furylmethylisonitriles 4d and 4e. 13 In a related alkylation, the metalated arylmethylisonitriles derived from 4a, 4b, and 4f were found to efficiently add to imidoyl chlorides 14 to form imidazoles 9 (entries 10-13). 15 The reaction extends the union of imidoyl chlorides with TosMIC 16 to less stabilized metalated isonitriles. Lithiated benzylisonitrile reacts with a chloroquinoline to afford the quinoline 10a (entry 14) while the isonitrile 4b was found to react with 2-chloro-4,6-dimethylpyrimidine to afford 11a (entry 15). The efficacious role of KHMDS in these cyclizations is likely related to the ability of hexamethyldisilazane, generated after deprotonation of the isonitrile, to facilitate the proton transfers. 
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